Sylentis Competitors and Similar CompaniesClear all
Sylentis's competitors and similar companies include Lexicon Pharmaceuticals, Omega Therapeutics and AnGes.
 Sylentis Sylentis is a biotechnology company focused on the development of ophthalmic drugs and therapies based on RNAi (gene silencing) technology. |  Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. |  AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine. | ||
Founding Date | Founding Date 2006 | Founding Date 1995 | Founding Date 2017 | Founding Date 1999 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Tres Cantos, ES HQ Madrid, ES Mountain View, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more | Locations Cambridge, US HQ | Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US |
Employees | Employees 51 | Employees 20216% increase | Employees 60 | Employees 5562% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 737.4 m | Valuation ($) 68.4 m | Valuation ($) 78.3 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) | Revenue (est.) $3.1m (FY, 2023) | Revenue (est.) ¥874.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $274k (FY, 2025) | Cost of goods N/A | Cost of goods ¥499.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $49.5m (FY, 2025) | Gross profit N/A | Gross profit ¥374.2m (FY, 2025) |
Net income | Net income N/A | Net income ($50.3m) (FY, 2025) | Net income ($97.4m) (FY, 2023) | Net income (¥5.1b) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 244.7m | Total funding raised $ 211m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company
Omega Therapeutics
HQ
Cambridge, US
Employees
60
Omega Therapeutics is an epigenomic medicine company.
View companyAnGes
HQ
Ibaraki, JP
Employees
55
AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
View company